Allogene Therapeutics Inc (ALLO)
2.11
+0.06
(+2.93%)
USD |
NASDAQ |
Nov 21, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Market Cap: 442.41M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 429.83M |
| November 19, 2024 | 444.50M |
| November 18, 2024 | 450.80M |
| November 15, 2024 | 475.96M |
| November 14, 2024 | 515.79M |
| November 13, 2024 | 570.31M |
| November 12, 2024 | 595.47M |
| November 11, 2024 | 647.89M |
| November 08, 2024 | 645.79M |
| November 07, 2024 | 668.85M |
| November 06, 2024 | 675.14M |
| November 05, 2024 | 626.92M |
| November 04, 2024 | 629.02M |
| November 01, 2024 | 570.31M |
| October 31, 2024 | 535.27M |
| October 30, 2024 | 553.08M |
| October 29, 2024 | 586.60M |
| October 28, 2024 | 561.46M |
| October 25, 2024 | 511.18M |
| October 24, 2024 | 532.13M |
| October 23, 2024 | 580.32M |
| October 22, 2024 | 586.60M |
| October 21, 2024 | 586.60M |
| October 18, 2024 | 594.98M |
| October 17, 2024 | 563.56M |
| Date | Value |
|---|---|
| October 16, 2024 | 597.08M |
| October 15, 2024 | 567.75M |
| October 14, 2024 | 550.99M |
| October 11, 2024 | 555.18M |
| October 10, 2024 | 548.89M |
| October 09, 2024 | 553.08M |
| October 08, 2024 | 574.03M |
| October 07, 2024 | 540.51M |
| October 04, 2024 | 565.65M |
| October 03, 2024 | 546.80M |
| October 02, 2024 | 530.04M |
| October 01, 2024 | 559.37M |
| September 30, 2024 | 586.60M |
| September 27, 2024 | 608.51M |
| September 26, 2024 | 568.78M |
| September 25, 2024 | 547.87M |
| September 24, 2024 | 558.33M |
| September 23, 2024 | 558.33M |
| September 20, 2024 | 585.51M |
| September 19, 2024 | 608.51M |
| September 18, 2024 | 602.24M |
| September 17, 2024 | 602.24M |
| September 16, 2024 | 577.15M |
| September 13, 2024 | 618.97M |
| September 12, 2024 | 556.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
383.67M
Minimum
Nov 29 2023
6.773B
Maximum
May 22 2020
2.237B
Average
1.562B
Median
Market Cap Benchmarks
| ANI Pharmaceuticals Inc | 1.173B |
| AIM ImmunoTech Inc | 13.47M |
| Perspective Therapeutics Inc | 202.09M |
| Protalix BioTherapeutics Inc | 122.97M |
| Armata Pharmaceuticals Inc | 75.98M |
Market Cap Related Metrics
| PS Ratio | 4467.43 |
| Price to Book Value | 0.9540 |
| Price | 2.11 |
| Earnings Yield | -73.93% |